|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Altea Therapeutics Corp., of Tucker, Ga., began Phase I trials for AT1391, a daily insulin patch designed to provide basal levels of insulin for diabetes patients. The product uses Altea's PassPort system, which is designed to deliver protein and peptide drugs, small molecules, genes and vaccines through the skin.
o Atrix Laboratories Inc., of Fort Collins, Colo., said Pfizer Inc., of New York, published preclinical data on CP-533,536, a bone growth/healing compound that uses Atrix's Atrigel drug delivery technology. The article appears in the May 27, 2003, issue of Proceedings of the National Academy of Sciences. The article reports that the compound promotes ...